U
IPCI

UBS’s Intellipharmaceuticals International Inc. IPCI Stock Holding History

UBS’s Portfolio IPCI Stock Details IPCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$5K Sell
150
-530
-78% -$15.3K ﹤0.01% 9527
2014
Q2 		$26K Hold
680
– – ﹤0.01% 7753
2014
Q1 		$30K Buy
+680
New +$27.2K ﹤0.01% 7550

Other funds holding IPCI

TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
FMBTD
First Midwest Bank Trust Division Joliet, Illinois $777M AUM 29.48% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
ARTA
A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

UBS's IPCI Position: Q3 2014 in Review

UBS reduced its Intellipharmaceuticals International Inc. (IPCI) stake by 45% in Q3 2014, selling an estimated $9.8K and leaving 417 shares worth $13K. The position accounts for ﹤0.01% of the portfolio, ranked #8567.

UBS first reported a position in IPCI in Q1 2014 and has held it in 3 quarters since. The position peaked at $29K in Q2 2014. 20 funds tracked by Wall St. Rank hold IPCI as of Q3 2014.

  • UBS held 417 shares of Intellipharmaceuticals International Inc. worth $13K as of Q3 2014.
  • UBS sold 340 Intellipharmaceuticals International Inc. shares in Q3 2014, an estimated $9.8K.
  • Intellipharmaceuticals International Inc. made up ﹤0.01% of UBS's portfolio in Q3 2014, its #8567 holding.
  • UBS first reported a position in Intellipharmaceuticals International Inc. in Q1 2014 and has held it in 3 quarters since.
  • UBS's Intellipharmaceuticals International Inc. position peaked at $29K in Q2 2014.
  • 20 funds tracked by Wall St. Rank held Intellipharmaceuticals International Inc. as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.